| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/29/2014 | CN103536750A Traditional Chinese medicine for treating sciatica |
| 01/29/2014 | CN103536746A Traditional Chinese medicine for treating stagnation of liver-qi and insufficiency of spleen |
| 01/29/2014 | CN103536735A Traditional Chinese medicine liquid medicine for preventing senile dementia |
| 01/29/2014 | CN103536734A Traditional Chinese medicine for treating heart and spleen deficiency type amnesia |
| 01/29/2014 | CN103536711A Tuckahoe Chinese medicine preparation |
| 01/29/2014 | CN103536701A Traditional Chinese medicinal composition with enhanced pain-relieving and calming effects and preparation method thereof |
| 01/29/2014 | CN103536698A New medicine application of traditional Chinese medicinal composition |
| 01/29/2014 | CN103536696A Oral liquid for enriching blood and soothing nerves, and preparation method thereof |
| 01/29/2014 | CN103536687A Health care product capable of improving sleep |
| 01/29/2014 | CN103536685A Traditional Chinese medicine for treating prosopalgia and cephalagra as well as amygdalitis and dental ulcer caused by tooth decay and periodontitis toothache |
| 01/29/2014 | CN103536673A Topical powder with strong enhanced immunity for removing food retention, bringing down fever and relieving cough and asthma, and application thereof |
| 01/29/2014 | CN103536671A Drug for treating ischialgia |
| 01/29/2014 | CN103536665A Cortex moutan Chinese medicine preparation |
| 01/29/2014 | CN103536658A Rhizoma corydalis Chinese medicinal preparation |
| 01/29/2014 | CN103536646A Medicine of drug pillow interior for treating insomnia |
| 01/29/2014 | CN103536609A Glycerophospholipids for the improvement of cognitive functions |
| 01/29/2014 | CN103536599A Non-hormonal steroid modulators of nf-kb for treatment of disease |
| 01/29/2014 | CN103536596A Transdermal delivery of diclofenac, carbamazepine and benzydamine |
| 01/29/2014 | CN103536574A Coenzyme Q10 soft capsule and preparation method thereof |
| 01/29/2014 | CN103536569A Rizatriptan monobenzoate tablet and preparation method thereof |
| 01/29/2014 | CN103536568A Orally disintegrating tablets containing lurasidone and preparation method thereof |
| 01/29/2014 | CN103536548A Oryzanol freeze-dried powder composition for injection, and preparation method thereof |
| 01/29/2014 | CN103536543A Oxiracetam composition freeze-dried powder for injection |
| 01/29/2014 | CN103536526A 帕罗西汀注射液及其制备方法 Paroxetine injection and its preparation method |
| 01/29/2014 | CN103536124A Longevity health herbal pillow |
| 01/29/2014 | CN103536123A Healthcare pillow interior |
| 01/29/2014 | CN103535734A Drug bag for improving sleep and preparation method thereof |
| 01/29/2014 | CN103083517B Traditional Chinese medicine for treating child cerebral palsy |
| 01/29/2014 | CN102908503B Traditional Chinese medicine pill for treating insomnia |
| 01/29/2014 | CN102908435B Temperance capsule |
| 01/29/2014 | CN102813766B Traditional Chinese medicine capsule for treating nervous tinnitus and tinnitus cerebri |
| 01/29/2014 | CN102784318B Preparation method of traditional Chinese medicine for treating frequent and urgent micturition insomnia |
| 01/29/2014 | CN102755543B Consciousness-restoring and epilepsy-relieving pill |
| 01/29/2014 | CN102755049B Quilt cover for treating hyperactivity of child |
| 01/29/2014 | CN102481368B Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast |
| 01/29/2014 | CN102370705B Externally applied medicine for treating prosopalgia |
| 01/29/2014 | CN102341112B Method and means for producing tissues and tissues obtained |
| 01/29/2014 | CN102234316B Polypeptides capable of enhancement of acid sensing ion channels 1a current, and use thereof |
| 01/29/2014 | CN102020588B Tricyclic compound with histone deacetylases inhibition activity and preparation method and application thereof |
| 01/29/2014 | CN101888990B Amide linked modulators of gamma-secretase |
| 01/29/2014 | CN101835779B Purine derivatives useful as PI3 kinase inhibitors |
| 01/29/2014 | CN101679355B Benzimidazole cannabinoid agonists |
| 01/29/2014 | CN101654435B N-benzyl quinoline carboxylic acid compound, combination and preparation method thereof |
| 01/29/2014 | CN101501007B Quinazoline derivative |
| 01/29/2014 | CN101400406B Compositions and methods of use for antibodies of dickkopf-1 and/or -4 |
| 01/29/2014 | CN101139267B White black falsehellebore alcohol derivative, analogue and preparation method and use thereof |
| 01/28/2014 | USRE44733 6-mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular block |
| 01/28/2014 | US8637539 Remedies for neuropathic pain and model animals of neuropathic pain |
| 01/28/2014 | US8637533 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 01/28/2014 | US8637527 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1 |
| 01/28/2014 | US8637523 Compounds for the reduction of beta-amyloid production |
| 01/28/2014 | US8637519 Heterocycle-substituted piperazino-dihydrothienopyrimidines |
| 01/28/2014 | US8637513 Heterocycle phenyl amide T-type calcium channel antagonists |
| 01/28/2014 | US8637512 Formulations and method of treatment |
| 01/28/2014 | US8637511 Aminopyrimidines useful as kinase inhibitors |
| 01/28/2014 | US8637501 Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof |
| 01/28/2014 | US8637474 Receptor modulators exhibiting neuroprotective and memory enhancing activities |
| 01/28/2014 | US8637031 Method of treating osteoarthritis with an antibody to NGF |
| 01/28/2014 | US8636997 Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist |
| 01/28/2014 | US8636985 Functional formulation in chewing gum |
| 01/28/2014 | CA2773555C Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, preparation and use thereof |
| 01/28/2014 | CA2745715C Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof |
| 01/28/2014 | CA2686468C Polyhydroxylated aromatic compounds for the treatment of amyloidosis |
| 01/28/2014 | CA2623450C Methods and compositions for improving cognitive function |
| 01/28/2014 | CA2611011C Treatment of cns disorders associated with mutations in genes encoding lysosomal enzymes |
| 01/28/2014 | CA2524036C Treatment of neurodegenerative conditions |
| 01/28/2014 | CA2431916C New therapeutic uses of smr1 peptides |
| 01/23/2014 | WO2014015338A1 Acetylated crystallin polypeptides and mimetics thereof as therapeutics agents |
| 01/23/2014 | WO2014015261A1 Regenerating functional neurons for treatment of disease and injury in the nervous system |
| 01/23/2014 | WO2014015247A1 Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions |
| 01/23/2014 | WO2014015125A1 Fused aminodihydrothiazine derivative salts and uses thereof |
| 01/23/2014 | WO2014015047A1 Compositions and methods to treat neurodegenerative diseases |
| 01/23/2014 | WO2014013497A1 Fatty acid derivatives for use in a method of treating depression and associated conditions |
| 01/23/2014 | WO2014013469A1 Carbamate/urea derivatives |
| 01/23/2014 | WO2014013313A1 Process for improved opioid synthesis |
| 01/23/2014 | WO2014013311A1 Process for improved opioid synthesis |
| 01/23/2014 | WO2014013258A1 Stem cell microparticles |
| 01/23/2014 | WO2014013076A1 Hexahydropyrrolothiazine compounds |
| 01/23/2014 | WO2014012851A1 Arylethynyl derivatives |
| 01/23/2014 | WO2014012593A1 Alkyl substituted 3-hydroxypyridines for the treatment of depression |
| 01/23/2014 | WO2013167112A8 Composition for nasal application |
| 01/23/2014 | WO2013153451A3 Controlled release formulations of opioids |
| 01/23/2014 | WO2012072256A3 Once daily formulation of lacosamide |
| 01/23/2014 | US20140024695 Methods of treating arthritic conditions using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline 1,3-dione |
| 01/23/2014 | US20140024658 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 01/23/2014 | US20140024621 Aminopyridine compounds and their uses |
| 01/23/2014 | US20140023722 Neural Scaffold Biomaterial |
| 01/22/2014 | EP2687593A1 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 01/22/2014 | EP2687532A1 Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these |
| 01/22/2014 | EP2687529A1 Condensed heterocyclic compound |
| 01/22/2014 | EP2687523A1 Novel phenylpyridine derivative and drug containing same |
| 01/22/2014 | EP2687516A1 Inhibitors of C-FMS Kinase |
| 01/22/2014 | EP2687513A1 Drugs for inhibiting aggregation of proteins invoved in diseases linked to protein aggregation and/or neurodegenerative diseases |
| 01/22/2014 | EP2687212A2 Medicament |
| 01/22/2014 | EP2686313A1 Benz imidazole derivatives as inhibitors of glutaminyl cyclase |
| 01/22/2014 | EP2686307A1 1,4-oxazepines as bace1 and/or bace2 inhibitors |
| 01/22/2014 | EP2686016A1 Antibody recognizing n-domain of midkine |
| 01/22/2014 | EP2686006A1 Composition comprising diamine oxidase for the prevention of hangover symptoms |
| 01/22/2014 | EP2686005A1 Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain |
| 01/22/2014 | EP2686004A1 Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome |